Skip to content
Open access · CC-BY via OpenAlex

High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models

Li Chen, Bangfu Wu, Li Mo, Huimin Chen, Xingzhu Yin, Ying Zhao, ZhaoYu Cui, Feipeng Cui, Liangkai Chen, Qianchun Deng, Chao Gao, Ping Yao, Yanyan Li, Yuhan Tang

Nature Communications · 2025 · ▲ 48 citations

Abstract

Accumulated senescent cells during the aging process are a key driver of functional decline and age-related disorders. Here, we identify ganoderic acid A (GAA) as a potent anti-senescent compound with low toxicity and favorable drug properties through high-content screening. GAA, a major natural component of Ganoderma lucidum, possesses broad-spectrum geroprotective activity across various species. In C. elegans, GAA treatment extends lifespan and healthspan(definition) as effectively as mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition). Administration of GAA also mitigates the accumulation of senescent cells and physiological decline in multiple organs of irradiation-stimulated premature aging mice, natural aged mice, and western diet-induced obese mice. Notably, GAA displays a capability to enhance physical function and adapts to conditional changes in metabolic demand as mice aged. Mechanistically, GAA directly binds to TCOF1 to maintain ribosome homeostasis and thereby alleviate cellular senescence(definition). These findings suggest a feasible senotherapeutic strategy for protecting against cellular senescence and age-related pathologies. Cellular senescence contributes to organismal aging and the onset of age-related diseases. Here the authors identify ganoderic acid A (GAA) as an anti-senescent compound by high-content screening, and report that it increases healthspan in C. elegans and in mice.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1038/s41467-025-58188-5
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Chen, L., Wu, B., Mo, L., Chen, H., Yin, X., Zhao, Y., Cui, Z., Cui, F., Chen, L., Deng, Q., Gao, C., Yao, P., Li, Y., &amp; Tang, Y. (2025). High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-025-58188-5
Vancouver
Chen L, Wu B, Mo L, Chen H, Yin X, Zhao Y, et al. High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models. Nature Communications. 2025. doi:10.1038/s41467-025-58188-5.
BibTeX
@article{li2025Highco, title = {High-content screening identifies ganoderic acid A as a senotherapeutic to prevent cellular senescence and extend healthspan in preclinical models}, author = {Li Chen and Bangfu Wu and Li Mo and Huimin Chen and Xingzhu Yin and Ying Zhao and ZhaoYu Cui and Feipeng Cui and Liangkai Chen and Qianchun Deng and Chao Gao and Ping Yao and Yanyan Li and Yuhan Tang}, journal = {Nature Communications}, year = {2025}, doi = {10.1038/s41467-025-58188-5}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings